Candriam S.C.A. Xenon Pharmaceuticals Inc. Transaction History

Candriam S.C.A.

$16.3 Billion
Q2 2024

A detailed history of Candriam S.C.A. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 521,836 shares of XENE stock, worth $20.2 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

521,836

Previous 560,884 6.96%

Holding current value

$20.2 Million

Previous $24.1 Million 15.74%

% of portfolio

0.13%

Previous 0.16%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$36.25 - $43.75 $1.42 Million - $1.71 Million	-39,048 Reduced 6.96%	521,836 $20.3 Million
Q1 2024 May 03, 2024	BUY	$42.66 - $50.04 $1.28 Million - $1.5 Million	30,000 Added 5.65%	560,884 $24.1 Million
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $1.12 Million - $1.81 Million	-39,000 Reduced 6.84%	530,884 $24.5 Million
Q3 2023 Nov 13, 2023	SELL	$34.16 - $39.73 $4.65 Million - $5.4 Million	-136,000 Reduced 19.27%	569,884 $19.5 Million
Q2 2023 Aug 08, 2023	SELL	$34.84 - $43.54 $464,138 - $580,039	-13,322 Reduced 1.85%	705,884 $27.2 Million
Q1 2023 May 12, 2023	SELL	$33.46 - $40.35 $558,045 - $672,957	-16,678 Reduced 2.27%	719,206 $25.7 Million
Q4 2022 Feb 13, 2023	SELL	$33.06 - $39.43 $826,500 - $985,750	-25,000 Reduced 3.29%	735,884 $29 Million
Q3 2022 Nov 10, 2022	SELL	$30.79 - $39.82 $3.15 Million - $4.07 Million	-102,256 Reduced 11.85%	760,884 $27.5 Million
Q2 2022 Aug 03, 2022	BUY	$25.44 - $35.16 $6.59 Million - $9.1 Million	258,886 Added 42.84%	863,140 $26.3 Million
Q1 2022 May 13, 2022	BUY	$25.09 - $33.13 $1.85 Million - $2.44 Million	73,743 Added 13.9%	604,254 $18.5 Million
Q4 2021 Feb 10, 2022	SELL	$15.6 - $35.4 $2.89 Million - $6.56 Million	-185,211 Reduced 25.88%	530,511 $16.6 Million
Q2 2021 Jul 20, 2021	BUY	$16.81 - $20.0 $12 Million - $14.3 Million	715,722 New	715,722 $13.3 Million

Others Institutions Holding XENE

# of Institutions

221

Shares Held

69.6M

Call Options Held

59.7K

Put Options Held

60.7K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.41B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account